Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.

BACKGROUND: Based on a large, representative unscreened cohort from Malmö, Sweden, we have recently reported that a single prostate-specific antigen (PSA) measurement at or before age 50 is a strong predictor of prostate cancer occurring up to 25 years subsequently. We aimed to determine whether th...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Ulmert, D, Cronin, A, Björk, T, O'Brien, M, Scardino, P, Eastham, J, Becker, C, Berglund, G, Vickers, A, Lilja, H
Бусад зохиолчид: Novak, J
Формат: Journal article
Хэл сонгох:English
Хэвлэсэн: BioMed Central 2008